蛋白質表徵與鑑定市場－全球產業規模、佔有率、趨勢、機會及預測：依產品/服務、應用、最終用途、地區、競爭格局分類，2021-2031年

全球蛋白質表徵和鑑定市場預計將從 2025 年的 157.2 億美元大幅成長至 2031 年的 356.3 億美元，複合年成長率為 14.61%。

蛋白質表徵是指精確測定蛋白質的品質、序列和結構，這對於確保生物系統中的安全性和有效性至關重要。該市場的主要成長要素來自蓬勃發展的生物製藥行業，在該行業中，嚴格的分析程序對於獲得新型生物製藥和生物相似藥的監管核准必不可少。此外，對藥物發現和蛋白質體學研究的大量投資（需要先進的分析工具）也推動了這一成長。例如，根據歐洲製藥工業協會聯合會 (EFPIA) 的報告，預計到 2024 年，歐洲的研發投資將達到 550 億歐元，這凸顯了對這些分析活動的強勁資金支持。

然而，由於質譜儀等先進設備需要大量資金投入，市場面臨嚴峻的挑戰。這些複雜的系統需要大量的初始投資和持續的維護成本，對小規模實驗室而言是一筆沉重的經濟負擔。此外，熟練複雜蛋白質數據解讀的專業人員短缺也是一個瓶頸，阻礙了這些技術的廣泛應用，並影響了整個行業的整體營運效率。

市場促進因素

製藥和生物技術產業研發投入的不斷成長是全球蛋白質表徵和鑑定市場的主要驅動力，直接促進了先進分析技術的應用。隨著藥物研發人員日益關注複雜的大分子療法，從早期藥物發現到後期品管的財務負擔也日益加重。資金的流入使得實驗室能夠投資高階質譜儀和層析法系統，這些設備對於精確測定蛋白質的純度、效力和穩定性至關重要。默克公司2025年2月發布的報告便是這項產業投資的顯著例證。報告顯示，根據其2024會計年度第四季及全年財務業績報告，默克2024會計年度的研發總支出為179億美元。如此龐大的資源投入直接轉化為對錶徵服務和分析儀器的持續需求，有助於降低臨床試驗的失敗率。

生物製藥和生物相似藥開發平臺的快速擴張是推動市場成長的另一個關鍵因素，也因此催生了比較分析研究的特定需求。與小分子藥物不同，生物製藥需要進行全面的結構分析，以確定其生物相似性，並確保生產過程的改進不會影響臨床療效。監管機構為核准更具成本效益的治療方案而施加的壓力，正推動產品上市數量的激增，而所有這些產品都依賴可靠的蛋白質鑑定數據。美國食品藥物管理局(FDA) 於 2025 年 1 月發布的《2024 年新藥認證年度報告》強調了這一趨勢，指出 2024 年核准的生物相似藥數量創歷史新高，達到 18 款。這些監管活動正在增強分析工具供應商的市場地位。例如，賽默飛世爾科技公司在 2025 年報告稱，其 2024 年全年銷售額達到 428.8 億美元，凸顯了業界對這些關鍵生命科學工作流程的大力支持。

市場挑戰

引進和維護先進分析儀器（尤其是質譜儀）所需的大量資本投入，是全球蛋白質表徵和鑑定市場成長的主要障礙。這些系統除了需要大量的初始投資外，還需要持續的校準、技術支援和專用耗材費用。這種成本結構對資金有限的小規模實驗室、學術機構和新興生物製藥公司造成了不成比例的影響，常常迫使它們推遲採購決策。因此，關鍵分析技術的普及速度直接放緩，限制了整體市場規模。

新興產業參與者面臨的嚴峻投資環境進一步加劇了這項財務負擔，限制了它們購買資本密集設備的能力。例如，根據生技創新組織（BIO）的報告，生技新創公司的資金籌措從2025年第一季的26億美元驟降至第二季的9億美元。可用資金的急劇減少迫使小規模的市場參與企業優先考慮業務生存而非基礎設施升級。因此，流入該行業的資本減少直接阻礙了關鍵蛋白質表徵工具的採購，進而減緩了整體市場擴張。

市場趨勢

隨著自動化、高通量樣品製備工作流程的日益普及，市場正在改變。這些工作流程有效解決了人工樣品處理的巨大瓶頸及其帶來的數據可重複性風險。實驗室正逐步採用自動化液體處理和微流體系統，以規範流程、最大限度地減少人為誤差，並滿足大規模臨床研究日益成長的生物樣本需求。這種轉變不僅提高了分析精度，還顯著提升了營運效率，使研究機構能夠在不相應增加人事費用的情況下擴展其蛋白質譜分析能力。業界對此標準化高通量解決方案的需求顯而易見。例如，Standard BioTools 在 2025 年 2 月發布的 2024 年第四季和 2025 年全年財報中公佈，全年銷售額達 1.751 億美元，凸顯了其對自動化技術的持續投資，這些技術旨在簡化複雜的生物表徵流程。

同時，蛋白質體學和多體學領域的跨學科研究融合，正將市場範圍從單一蛋白質分析擴展到更全面的系統生物學觀點。研究人員擴大將蛋白質組學數據與基因組學和轉錄組學數據整合，以全面了解疾病機制。這需要高通量、高靈敏度的檢測平台來有效地連接這些不同的生物學層面。這一趨勢也推動了主要儀器供應商之間的快速整合。每家公司都致力於提供能夠無縫整合質譜和其他高解析度鑑定技術的綜合性多組體學解決方案。賽默飛世爾科技公司於2024年7月以約31億美元收購Olink Holding AB，便是這項策略整合的典型例證。根據該公司的新聞稿，此次收購旨在增強其在快速發展的蛋白質組學和多體學領域的實力。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：蛋白質表徵與鑑定的全球市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品/服務（耗材、設備、服務）分類
  • 按應用領域（藥物發現與開發、臨床診斷、其他）
  • 依最終用途分類（製藥和生物技術公司、學術研究機構、受託研究機構、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美蛋白質表徵與鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲蛋白質表徵與鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區蛋白質表徵與鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東與非洲蛋白質表徵與鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲蛋白質表徵與鑑定市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球蛋白質表徵與鑑定市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen NV
• Sartorius AG

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Protein Characterization and Identification Market is expected to expand significantly, growing from USD 15.72 Billion in 2025 to USD 35.63 Billion by 2031, at a Compound Annual Growth Rate (CAGR) of 14.61%. Protein characterization involves precisely determining the mass, sequence, and structure of proteins, which is crucial for ensuring their safety and effectiveness within biological systems. This market's primary growth engine is the expanding biopharmaceutical industry, where stringent analytical procedures are indispensable for securing regulatory approvals for new biologics and biosimilars. Further boosting this growth are substantial investments in drug discovery and proteomics research, which demand sophisticated analytical tools. For example, the European Federation of Pharmaceutical Industries and Associations reported an estimated €55,000 million invested in R&D in Europe in 2024, underscoring the robust financial backing for these analytical activities.

However, the market faces a significant challenge due to the high capital expenditure required for advanced instruments such as mass spectrometers. These complex systems necessitate considerable upfront investment and ongoing maintenance costs, making them financially prohibitive for smaller laboratories. Additionally, a scarcity of skilled professionals proficient in interpreting intricate protein data creates a bottleneck, hindering the widespread adoption of these technologies and impeding operational efficiency across the sector.

Market Driver

Increased spending on research and development (R&D) within the pharmaceutical and biotechnology sectors is a fundamental driver for the Global Protein Characterization and Identification Market, directly boosting the uptake of advanced analytical technologies. As drug developers increasingly focus on complex large-molecule therapeutics, the financial commitment for both early-stage discovery and late-stage quality control has escalated. This influx of capital enables laboratories to acquire high-end mass spectrometry and chromatography systems, essential for accurately defining protein purity, potency, and stability. A notable example of this industrial investment is Merck & Co.'s report in February 2025, detailing a total R&D expense of $17.9 billion for the fiscal year 2024, as outlined in their 'Fourth-Quarter and Full-Year 2024 Financial Results.' Such significant resource allocation directly translates to sustained demand for characterization services and instrumentation, which helps reduce failure rates in clinical trials.

The rapid expansion of development pipelines for biologics and biosimilars represents another critical factor accelerating market growth, creating a specific demand for comparative analytical studies. Unlike small-molecule drugs, biologics require thorough structural analysis to demonstrate biosimilarity or confirm that manufacturing alterations do not compromise clinical efficacy. The regulatory impetus to approve more cost-effective treatment alternatives has led to a surge in product launches, all of which depend on robust protein identification data. The U.S. Food and Drug Administration's '2024 New Drug Therapy Approvals Annual Report,' released in January 2025, highlights this trend by noting a record 18 biosimilar product approvals in 2024. This heightened regulatory activity strengthens the vendor landscape for analytical tools; for instance, Thermo Fisher Scientific reported full-year 2024 revenue of $42.88 billion in 2025, illustrating the substantial industry support for these vital life sciences workflows.

Market Challenge

The substantial capital investment required for acquiring and maintaining advanced analytical instruments, particularly mass spectrometers, poses a significant impediment to the growth of the Global Protein Characterization and Identification Market. These systems demand a considerable initial financial outlay, further compounded by ongoing expenses for calibration, technical support, and specialized consumables. This cost structure disproportionately affects smaller laboratories, academic institutions, and nascent biopharmaceutical companies operating with limited capital, often forcing them to postpone purchasing decisions. Consequently, this directly slows the adoption rate of essential analytical technologies and restricts the overall market volume.

This financial burden is exacerbated by a tighter investment climate for emerging industry players, which curtails their capacity to purchase capital-intensive equipment. For example, the Biotechnology Innovation Organization reported a sharp decline in biotech startup funding from $2.6 billion in the first quarter to $900 million in the second quarter of 2025. This substantial reduction in available liquidity compels smaller market participants to prioritize operational survival over infrastructure upgrades. As a result, the diminished capital flow into the sector directly hinders the procurement of crucial protein characterization tools, thereby decelerating the market's overall expansion.

Market Trends

The market is being transformed by the increasing adoption of automated high-throughput sample preparation workflows, which effectively address the crucial bottleneck of manual sample handling and its associated risks to data reproducibility. Laboratories are progressively integrating automated liquid handling and microfluidic systems to standardize procedures, minimize human error, and manage the growing volume of biological samples required for large-scale clinical studies. This shift not only enhances analytical precision but also significantly boosts operational efficiency, enabling research facilities to expand their protein profiling capabilities without a proportional increase in labor costs. The demand for such standardized, high-plex solutions is evident in the industry; for instance, Standard BioTools reported a full-year revenue of $175.1 million in February 2025, according to their 'Fourth Quarter and Full Year 2024 Financial Results,' highlighting sustained investment in automated technologies that streamline complex biological characterization.

Concurrently, the convergence of proteomics with multi-omics interdisciplinary studies is broadening the market's scope beyond isolated protein analysis, moving towards a comprehensive systems biology perspective. Researchers are increasingly integrating proteomic data with genomic and transcriptomic profiles to achieve a holistic understanding of disease mechanisms. This necessitates platforms capable of high-throughput and high-sensitivity detection to effectively bridge these different biological layers. This trend is also driving rapid consolidation among major instrument vendors, who aim to offer comprehensive multi-omic solutions that seamlessly integrate mass spectrometry with other high-resolution identification technologies. A key example of this strategic consolidation is Thermo Fisher Scientific's acquisition of Olink Holding AB for approximately $3.1 billion in July 2024, as stated in their press release, specifically to enhance their capabilities in the burgeoning proteomics and multi-omics sector.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Eurofins Scientific
• Merck KGAA
• Promega Corporation
• Qiagen N.V.
• Sartorius AG

Report Scope

In this report, the Global Protein Characterization and Identification Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Protein Characterization and Identification Market, By Product & Services

• Consumables
• Instruments
• Services

Protein Characterization and Identification Market, By Application

• Drug Discovery & Development
• Clinical Diagnosis
• Others

Protein Characterization and Identification Market, By End-Use

• Pharmaceuticals & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

Protein Characterization and Identification Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Protein Characterization and Identification Market.

Available Customizations:

Global Protein Characterization and Identification Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Protein Characterization and Identification Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product & Services (Consumables, Instruments, Services)
  • 5.2.2. By Application (Drug Discovery & Development, Clinical Diagnosis, Others)
  • 5.2.3. By End-Use (Pharmaceuticals & Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Protein Characterization and Identification Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product & Services
  • 6.2.2. By Application
  • 6.2.3. By End-Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Protein Characterization and Identification Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product & Services
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-Use
  • 6.3.2. Canada Protein Characterization and Identification Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product & Services
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-Use
  • 6.3.3. Mexico Protein Characterization and Identification Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product & Services
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-Use

7. Europe Protein Characterization and Identification Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product & Services
  • 7.2.2. By Application
  • 7.2.3. By End-Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Protein Characterization and Identification Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product & Services
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-Use
  • 7.3.2. France Protein Characterization and Identification Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product & Services
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-Use
  • 7.3.3. United Kingdom Protein Characterization and Identification Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product & Services
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-Use
  • 7.3.4. Italy Protein Characterization and Identification Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product & Services
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-Use
  • 7.3.5. Spain Protein Characterization and Identification Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product & Services
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-Use

8. Asia Pacific Protein Characterization and Identification Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product & Services
  • 8.2.2. By Application
  • 8.2.3. By End-Use
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Protein Characterization and Identification Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product & Services
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-Use
  • 8.3.2. India Protein Characterization and Identification Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product & Services
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-Use
  • 8.3.3. Japan Protein Characterization and Identification Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product & Services
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-Use
  • 8.3.4. South Korea Protein Characterization and Identification Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product & Services
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-Use
  • 8.3.5. Australia Protein Characterization and Identification Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product & Services
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-Use

9. Middle East & Africa Protein Characterization and Identification Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product & Services
  • 9.2.2. By Application
  • 9.2.3. By End-Use
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Protein Characterization and Identification Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product & Services
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-Use
  • 9.3.2. UAE Protein Characterization and Identification Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product & Services
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-Use
  • 9.3.3. South Africa Protein Characterization and Identification Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product & Services
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-Use

10. South America Protein Characterization and Identification Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product & Services
  • 10.2.2. By Application
  • 10.2.3. By End-Use
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Protein Characterization and Identification Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product & Services
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-Use
  • 10.3.2. Colombia Protein Characterization and Identification Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product & Services
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-Use
  • 10.3.3. Argentina Protein Characterization and Identification Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product & Services
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Protein Characterization and Identification Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Agilent Technologies, Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bio-Rad Laboratories, Inc.
• 15.3. Bruker Corporation
• 15.4. Thermo Fisher Scientific Inc.
• 15.5. Danaher Corporation
• 15.6. Eurofins Scientific
• 15.7. Merck KGAA
• 15.8. Promega Corporation
• 15.9. Qiagen N.V.
• 15.10. Sartorius AG

16. Strategic Recommendations

17. About Us & Disclaimer